These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19056413)

  • 21. Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances?
    Bricout V; Wright F
    Eur J Appl Physiol; 2004 Jun; 92(1-2):1-12. PubMed ID: 15042372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism.
    Baume N; Avois L; Schweizer C; Cardis C; Dvorak J; Cauderay M; Mangin P; Saugy M
    Clin Chem; 2004 Feb; 50(2):355-64. PubMed ID: 14633920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of 19-norandrosterone of endogenous origin in man: quantitative analysis by gas chromatography-mass spectrometry.
    Dehennin L; Bonnaire Y; Plou P
    J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(2):301-7. PubMed ID: 10052703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug testing.
    Cowan DA
    Essays Biochem; 2008; 44():139-48. PubMed ID: 18384288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection of androstenedione abuse in sport: a mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite.
    Cawley AT; Trout GJ; Kazlauskas R; George AV
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4147-57. PubMed ID: 19025884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urinary nandrolone metabolites in antidoping control].
    Pépin G; Vayssette F; Gaillard Y
    Ann Pharm Fr; 2001 Sep; 59(5):345-9. PubMed ID: 11787429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of 19-nortestosterone sulphate and boldenone sulphate in urine from male horses using liquid chromatography/tandem mass spectrometry.
    Grace PB; Drake EC; Teale P; Houghton E
    Rapid Commun Mass Spectrom; 2008 Oct; 22(19):2999-3007. PubMed ID: 18777513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry.
    Van Eenoo P; Van Gansbeke W; De Brabanter N; Deventer K; Delbeke FT
    J Chromatogr A; 2011 May; 1218(21):3306-16. PubMed ID: 20970803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin.
    Le Bizec B; Bryand F; Gaudin I; Monteau F; Poulain F; Andre F
    Steroids; 2002 Feb; 67(2):105-10. PubMed ID: 11755174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excretion of norsteroids' phase II metabolites of different origin in human.
    Guay C; Goudreault D; Schänzer W; Flenker U; Ayotte C
    Steroids; 2009 Mar; 74(3):350-8. PubMed ID: 19027768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of nandrolone metabolites in urine after the therapeutic administration of an ophthalmic solution.
    Avois L; Mangin P; Saugy M
    J Pharm Biomed Anal; 2007 May; 44(1):173-9. PubMed ID: 17391892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of a challenging subset of World Anti-Doping Agency-banned steroids and antiestrogens by LC-MS-MS.
    Borges CR; Miller N; Shelby M; Hansen M; White C; Slawson MH; Monti K; Crouch DJ
    J Anal Toxicol; 2007 Apr; 31(3):125-31. PubMed ID: 17579958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of exogenous nandrolone metabolite in horse urine by gas chromatography/combustion/carbon isotope ratio mass spectrometry.
    Yamada M; Kinoshita K; Kurosawa M; Saito K; Nakazawa H
    J Pharm Biomed Anal; 2007 Nov; 45(4):654-8. PubMed ID: 17714906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gas chromatography-combustion-isotope ratio mass spectrometry analysis of 19-norsteroids: application to the detection of a nandrolone metabolite in urine.
    Mathurin JC; Herrou V; Bourgogne E; Pascaud L; de Ceaurriz J
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(2):267-75. PubMed ID: 11499480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Study: Atypical δ
    Hülsemann F; Gougoulidis V; Schertel T; Fusshöller G; Flenker U; Piper T; Thevis M
    Drug Test Anal; 2018 Nov; 10(11-12):1728-1733. PubMed ID: 30230253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Norandrostenolone and noretiocholanolone: metabolite markers].
    Kintz P; Cirimele V; Ludes B
    Acta Clin Belg; 1999; 53 Suppl 1():68-73. PubMed ID: 10216987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas chromatography-mass spectrometry method for the analysis of 19-nor-4-androstenediol and metabolites in human plasma: application to pharmacokinetic studies after oral administration of a prohormone supplement.
    Torrado S; Segura J; Farré M; Ventura R
    Steroids; 2008 Aug; 73(7):751-9. PubMed ID: 18423786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.
    Thomas A; Kohler M; Schänzer W; Kamber M; Delahaut P; Thevis M
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluation of the effects of anti-fungals, benzodiazepines and non-steroidal anti-inflammatory drugs on the glucuronidation of 19-norandrosterone: implications on doping control analysis.
    Palermo A; Alessi B; Botrè F; de la Torre X; Fiacco I; Mazzarino M
    Drug Test Anal; 2016 Sep; 8(9):930-9. PubMed ID: 26480899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry.
    Schrader Y; Thevis M; Schänzer W
    Drug Metab Dispos; 2006 Aug; 34(8):1328-35. PubMed ID: 16714373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.